178 related articles for article (PubMed ID: 32847629)
1. Novel genetic alteration in congenital melanocytic nevus: MAP2K1 germline mutation with BRAF somatic mutation.
Zou Y; Sun Y; Zeng X; Liu Y; Cen Q; Gu H; Lin X; Cai R; Chen H
Hereditas; 2020 Aug; 157(1):35. PubMed ID: 32847629
[TBL] [Abstract][Full Text] [Related]
2. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
3. The association of BRAF V600E gene mutation with proliferative activity and histopathological characteristics of congenital melanocytic nevi in children.
Chen J; Zhang G; Liu X; Tu P
An Bras Dermatol; 2023; 98(4):498-505. PubMed ID: 37156689
[TBL] [Abstract][Full Text] [Related]
4. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.
Polubothu S; McGuire N; Al-Olabi L; Baird W; Bulstrode N; Chalker J; Josifova D; Lomas D; O'Hara J; Ong J; Rampling D; Stadnik P; Thomas A; Wedgeworth E; Sebire NJ; Kinsler VA
Br J Dermatol; 2020 Feb; 182(2):434-443. PubMed ID: 31111470
[TBL] [Abstract][Full Text] [Related]
5. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.
Charbel C; Fontaine RH; Malouf GG; Picard A; Kadlub N; El-Murr N; How-Kit A; Su X; Coulomb-L'Hermine A; Tost J; Mourah S; Aractingi S; Guégan S
J Invest Dermatol; 2014 Apr; 134(4):1067-1074. PubMed ID: 24129063
[TBL] [Abstract][Full Text] [Related]
6. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases.
Alayed K; Medeiros LJ; Patel KP; Zuo Z; Li S; Verma S; Galbincea J; Cason RC; Luthra R; Yin CC
Hum Pathol; 2016 Jun; 52():61-7. PubMed ID: 26980021
[TBL] [Abstract][Full Text] [Related]
7. Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH.
McGinnis LM; Nybakken G; Ma L; Arber DA
Am J Surg Pathol; 2018 Jul; 42(7):885-890. PubMed ID: 29649018
[TBL] [Abstract][Full Text] [Related]
8. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi.
Papp T; Schipper H; Kumar K; Schiffmann D; Zimmermann R
Melanoma Res; 2005 Oct; 15(5):401-7. PubMed ID: 16179867
[TBL] [Abstract][Full Text] [Related]
10. BRAF somatic mutations in malignant melanoma and melanocytic naevi.
Thomas NE
Melanoma Res; 2006 Apr; 16(2):97-103. PubMed ID: 16567964
[TBL] [Abstract][Full Text] [Related]
11. BRAF mutations are common somatic events in melanocytic nevi.
Kumar R; Angelini S; Snellman E; Hemminki K
J Invest Dermatol; 2004 Feb; 122(2):342-8. PubMed ID: 15009715
[TBL] [Abstract][Full Text] [Related]
12. MAP2K1-mutated melanocytic tumors have reproducible histopathologic features and share similarities with melanocytic tumors with BRAF V600E mutations.
Alomari AK; Harms PW; Andea AA; Warren SJ
J Cutan Pathol; 2023 Dec; 50(12):1083-1093. PubMed ID: 37565534
[TBL] [Abstract][Full Text] [Related]
13. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
[TBL] [Abstract][Full Text] [Related]
14. NRAS p.Q61R/K allele load is correlated to different phenotypes of congenital melanocytic naevi.
Zhao X; Dai Y; Zhang L; Liu Y; Chen H; Yue X; Yu L
Clin Exp Dermatol; 2022 Dec; 47(12):2201-2207. PubMed ID: 35962610
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
Fumero-Velázquez M; Hagstrom M; Dhillon S; Geraminejad T; Olivares S; Donati M; Nosek D; Waldenbäck P; Kazakov D; Sheffield BS; Tron VA; Gerami P
Am J Surg Pathol; 2023 Dec; 47(12):1438-1448. PubMed ID: 37773074
[TBL] [Abstract][Full Text] [Related]
16. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.
Bauer J; Curtin JA; Pinkel D; Bastian BC
J Invest Dermatol; 2007 Jan; 127(1):179-82. PubMed ID: 16888631
[TBL] [Abstract][Full Text] [Related]
17. Congenital melanocytic nevi: update in genetics and management.
Price HN
Curr Opin Pediatr; 2016 Aug; 28(4):476-82. PubMed ID: 27307047
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
[TBL] [Abstract][Full Text] [Related]
19. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J
J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577
[TBL] [Abstract][Full Text] [Related]
20. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features.
Kiuru M; Tartar DM; Qi L; Chen D; Yu L; Konia T; McPherson JD; Murphy WJ; Fung MA
J Am Acad Dermatol; 2018 Aug; 79(2):221-229. PubMed ID: 29653212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]